March 26th, 2012.

A few days ago, I had this interesting conversation with a patient’s son. He told me about his family’s experiences with homeopathy in the past.

——————

His own case – at a young age, he had developed a kind of hip joint degeneration where the doctors insisted that nothing could be done for him apart from a hip replacement. He would not be able to walk normally without a surgery since the cartilage was all gone as well. He was patched up with plates and screws and could only walk with crutches.

He visited a homeopath in Pune, a Dr. Phatak. He was an old man who examined him and looked at his XRays and gave his verdict. “Good carpentry, but that’s about it.”. The patient asked him what he could achieve since there was such major problems with the joint. The old doctor just laughed and told him, ” I am an old man. I do not know the answers to your questions. You just enjoy the sweet medicines.”

6 months later, this young man could walk normally without crutches. He visited the old doctor who was on his deathbed. When our young man walked in and stood there, an obvious testament to what Dr. Phatak’s homeopathy had achieved, the old doctor just smiled and joined his hands in the old Indian greeting. He passed away the next day.

——————

This young man narrated another incident where a lady had a ping-pong ball sized brain tumour. The homeopath (don’t know who) laughed and guaranteed that he’d make it vanish. And that’s exactly what happened, much to the disbelief of the allopaths.

——————-

Such feel-good true stories and wonderful confidence is truly heart-warming.

 

Jan 21st 2014.

A controversy is raging in India at this point in time over whether homeopaths should be allowed to practice allopathy after a 1 year bridge course in Pharmacology. The Courts have given permission but the allopathic associations are up in arms against in and will probably move court against it.

In today’s Mumbai Mirror, part of The Times of India group, an article by Dr. Altaf Patel was published – Admission of Failure – this article tries to imply that homeopaths want to practice allopathy because they see the failure of alternative systems of medicine.  The article reeks of bias and hence I felt the need to respond to it. I have posted the same comments on Mumbai Mirror’s website, we shall see if the newspaper will publish a contrary view.

————————————————————————

With due respect to Dr. Patel’s views, I have to differ. There are several angles to this issue, hence it is inappropriate to say that failure of alternative systems of medicine make homeopaths want to practice allopathy.

I will first introduce myself by saying that I am a homeopath and proud to be one. I joined my homeopathic college (despite having the required percentage for entry to government/municipal MBBS colleges)  because I wanted to study homeopathy – I grew up with homeopathic medicines and I know what they can achieve when well-practised.  Saying that, I also know that a majority of students join homeopathic colleges because they have missed admission to MBBS colleges.

Regarding course study, homeopaths study all the subjects an MBBS student studies except Pharmacology. We have homeopathic subjects in addition – which are very detailed subjects; hence I would actually conclude that the homeopathic course is more intensive than the MBBS course. Homeopathy is a system of medicine (I refuse to call it alternative) that seeks to cure a person’s ailments from the root. Real cure; which is very different from just palliation or suppression that is the mainstay of allopathic treatment.  It is easy to mask symptoms and troubles with strong chemical drugs; bringing about an inner real resolution of health problems by safe energy medicine is much more difficult and challenging.

It is a sad fact that many homeopaths do not want to take up that challenge. It is an easy way out to practice allopathy and earn their money. It may also be reflective of the quality of homeopathic education outside larger cities. It is probable that colleges in small towns are unable to impart enough skills and knowledge to fledgling homeopaths. Since good homeopathy is difficult to practice,  this probably leaves a lot of homeopathic graduates in the lurch, unable to practice good homeopathy and hence unable to earn decent money. This makes them want the alternative of practising as allopathic GPs which is not that difficult with average pharmacology knowledge. (I am not talking about the extra skills and knowledge that a post-graduate allopath acquires after many years of dedication and hard work).

Dr. Patel writes that he does not see allopaths wanting to practise homeopathy or other systems of medicine. Again I need to differ. The founder of the homeopathic system of medicine was an allopath to start with, who quit allopathic practice because his conscience did not allow him to continue. Even today, there are plenty of allopathically qualified physicians in India and abroad who, having an open mind and a strong conscience, have chosen, voluntarily to learn and practice homeopathy because they find it a superior system of medicine to bring about true healing.  There are also plenty of allopaths who refer patients to homeopaths when they feel the need. In fact, Dr. Patel would be well-advised to contact some of them and discuss pros and cons of different systems of medicine before making biased blanket statements.

———————————————————————————

UPDATE:

Well, they did publish it as comment on the article web page. There are some other worthy replies there –

http://www.mumbaimirror.com/columns/columnists/dr-altaf-patel/Admission-of-failure/articleshow/29124304.cms

Many ‘natural’ home remedies are cited as being cure-alls. Some work, some don’t. It is my personal belief that not everything suits everyone, but some of these home remedies may work for many people.

Here is a blog post I came across which I want to save for future reference – and what better place to save it than here where it might be of help to others too.

http://www.undergroundhealth.com/is-apple-cider-vinegar-really-a-powerful-healing-tonic-science-says-yes/

Yes, I’ve heard a lot about apple cider vinegar – I’m going to give it a try. After all, in moderation, it cannot harm and it will probably be very useful in alkalinizing the body – something that is very important for good health.

I will be happy to hear from others about their own experiences with this. I’ll put mine up too, when there’s something to report.

So here’s to Apple Cider Vinegar!

As a homeopath, I oppose the bridge course which is being contemplated for practitioners of homeopathy and other AYUSH (Ayurveda, Unani, Siddhi and Homeopathy) streams. The bridge course will allow AYUSH practitioners in India to practise basic conventional medicine. Here are my thoughts on this and I write it from the point of view of homeopathy being my field of medicine:

1. We have a very effective and strong system of medicine ourselves, so why do we need to prescribe conventional medicine? In an emergency, if life-saving conventional treatment is needed (if the homeopath is not skilled or confident enough of treating it), patients can go to trained doctors in that field. The bridge course is not going to provide high-level ER training in any case.

2. It is said that the reason the government is planning this move is because there are insufficient doctors in rural areas and people living in such places have no access to healthcare. Fine. Why does rural India need conventional treatment only? Why can’t the other systems of medicine be practised there? In fact, this is a good chance to show, in comparative terms, how the other systems of medicine contribute positively to healthcare.

3. This bridge course is not going to help the cause of AYUSH. As students and young practitioners, many want to practise conventional medicine because of status and the perception of higher incomes. It is also a fact that to be a good homeopathic physician, one needs a great level of skill which only comes with hard work and constant learning. It is not as easy as prescribing ‘this for that’. Hence, this bridge course will serve as a back-door entry to conventional medicine practice and will be an escape route to avoid putting in the effort needed to be good homeopaths. Over time, this will reduce the number of skilled homeopaths and will be a dangerous matter for the future progress of our system of medicine. I presume the same would be the case for the other AYUSH streams.

4. Pharmaceutical companies will be very happy at the increase in their profits by getting lakhs of more practitioners who will prescribe their medicines.

5. As it is, conventional medicines unfortunately have loads of side effects. We regularly see patients in our practices, who come for problems and actual diseases that have arisen due to some side-effects of conventional therapy. It is possible that the AYUSH practitioner will be easily blamed for every side-effect that a patient suffers from. The side-effect will be attributed, not to the chemical drug which is actually responsible, but to a lack of skill in the AYUSH practitioner.

6. As a final point, let the Government ensure that every student receives good training and practical experience before they venture out as physicians. Let every physician develop the skill, and practise the field of medicine they were trained in. As homeopaths, let us not forget that we have the possibility of doing great things to improve the lives of our patients, bringing cure in so-many problematic chronic cases, and yes, we have the ability to be life-savers as well, if sufficiently skilled in our science. And this satisfies the soul. Isn’t it worth it?

 

In recent times, when several countries have clamped down on the rights and freedom of individuals to make choices for the health of themselves and their children, lots of articles have been circulating, accusing non-vaccinated populations for spreading diseases.

Fear-mongering is one of the easiest ways to scare a population into vaccinating. Hardly anyone questions motives or seeks data on what vaccines do or do not do.

The fact that vaccine manufacturers have been given immunity from any lawsuits resulting from vaccine damage is mind boggling. When Mc Donalds can be sued over a cup of hot coffee, vaccine maunfacturers cannot be sued for lifetime damage or even death resulting from vaccines. The US government has a VAERS program, Vaccine Adverse Event Reporting System, and data shows that millions are paid out every year for vaccine damage in cases where it has been conclusively proved that damage resulted from the vaccines. However, the government payout occurs from tax payers’ money, so the vaccine manufacturers laugh their way to the bank, with no motivation to make vaccines any safer.

Tetyana Obukhanych, Ph.D., came to the USA from Ukraine to pursie her education. In 2006, she defended her Ph.D. thesis in Immunology at the Rockefeller University, New York, NY. She subsequently held postdoctoral research training appointments in prominent immunology laboratories affiliated with Harvard Medical School and Stanford University School of Medicine.  In 2015, she became a Founding Director of Physicians for Informed Consent, a 501(c)(3) nonprofit dedicated to safeguarding informed consent in vaccination and educating the public on infectious disease and the immune system.

Dr. Obukhanych’s personal reason to start questioning vaccination programs began with her desire to gain clarity about why she ended up contracting childhood diseases for which she was fully vaccinated.  Indoctrinated to believe that the equivalence of vaccine immunity and naturally-acquired immunity has been scientifically established, Dr. Obukhanych nevertheless took a “second” look at the relevant scientific findings.  Her e-book Vaccine Illusion articulates a view that challenges mainstream assumptions and theories of lifelong vaccine immunity.

Her personal journey from disillusionment with the vaccination paradigm toward embracing the immune system care paradigm has motivated her to lecture at conferences and educational events throughout the USA and Canada.  Dr. Obukhanych’s mission is to promote the understanding of the immune system’s optimal function for benign resolution of infections, thereby preventing health complications and deaths from infectious diseases.

My first introduction to Dr. Tetyana Obukhanych was from reading an article of hers on someone’s blog.  Here, she has written an open letter explaining why unvaccinated children pose no risk to their vaccinated counterparts.

http://asheepnomore.net/2017/05/15/harvard-unvaccinated-children-pose-zero-risk/

On her website, I have found links to some more articles of interest in connection with vaccination -

http://www.tetyanaobukhanych.com/articles/my-journey-of-disillusionment

http://www.tetyanaobukhanych.com/herd_immunity.html

http://www.tetyanaobukhanych.com/tetanus_shot.html

Worth reading!

As I always say, everyone has the right to make informed decisions – coerced decisions encroach on one’s fundamental rights.

 

Conventional medicine has been treating cancers with surgery, chemotherapy and radiation since decades, yet, more and more patients are looking towards other systems for help in the fight against cancer, in addition to conventional treatments. Why is that? It is obvious that current methods of treating cancer are not being truly successful and after a brief respite, the cancer often tends to flare up again with rapid deterioration of the patient. The treatment methods also leave the patient debilitated and weak, with their systems no longer being able to cope with even minor demands. If life is prolonged, the quality of life is indeed questionable. This has led to the field of Integrative Oncology where complementary and alternative methods are used, in conjunction with standard conventional measures of cancer treatment.

Integrative Oncology methods take a more holistic approach. With this approach, one realises that the cancer cells themselves are not the villains. They are just the manifestation of something going wrong within the defence mechanisms of the body. It is now known that tumour development is preceded by a pre-tumour phase that may persist for years if not decades. There is a gradual failure of the immune system with the system becoming unable to distinguish between self and non-self. A healthy organism with a fully functional immune system identifies malfunctioning cells as alien and destroys them. Plenty of such cells arise from time to time in every individual. Failure of the monitoring system may result in de-differentiation of cells in certain organs which are then no longer under central control. These cells begin to program their own ‘circuit diagram’ and it is then possible that they may proliferate without any control. The code of those deviant cells no longer connects with the ‘human being’ program. This is the view now taken by modern molecular biologists and it confirms the statements made many years ago by Rudolf Steiner, the founder of Anthroposophy.

In the early part of the 20th century it was Rudolf Steiner, PhD., an Austrian natural scientist and philosopher, who established Anthroposophic Medicine as one of the many developments he gave the impetus for. The word anthroposophy is derived from the Greek words anthropos=man and sophia=wisdom. Anthroposophy represents a way of dealing with science and life issues, in general, in a holistic way. It incorporates all fields of modern science into a spiritual and comprehensible approach. Rudolf Steiner was not a physician. Therefore, he founded Anthroposophical Medicine and the Medical Section at the Goetheanum (in Dornach, Switzerland) in association with the Dutch physician Dr. Ita Wegman (1876 to 1943). As early as 1917, Rudolf Steiner suggested the injection of mistletoe extracts for the treatment of cancer. It was Dr. Ita Wegman who in the early 1920s introduced the mistletoe preparation Iscador into actual cancer treatment.

Mistletoe 5Mistletoe is one of the most widely studied complementary and alternative medicine therapies in people with cancer. In Europe, preparations made from European mistletoe are among the most prescribed drugs for patients with cancer. Mistletoe 1

Mistletoe extracts are marketed under several trade names, such as Iscador, Helixor, both of which are available in Europe. Helixor mistletoe products were developed in the 1970s by the non-profit Association for Leukemia and Cancer Therapy in an attempt to improve the therapeutic success with Viscum Album through a new manufacturing process. Since 1975, manufacturing and marketing are in the hands of Helixor Heilmittel GmbH.

There are about 1400 mistletoe species around the world. One thing that they all have in common is that they do not root in the mineral soil but live on other, generally woody, plants. Only white-berried mistletoe (Viscum Album) is used to treat cancer.

Since I have already elaborated on Iscador in another article, here I will give an introduction to Helixor. Helixor is a composition of purely aqueous fresh plant extracts from the white-berry mistletoe. It is produced using special rhythmic flow methods developed by the Helixor company in Germany and without using fermentation (Iscador is fermented).

There are three main types of Helixor – A, M and P.

  • Helixor A (Abietis) made from fir mistletoe.
  • Helixor M (Mali) made from apple tree mistletoe.
  • Helixor P (Pini) made from pine mistletoe.

Mistletoe 3Mistletoe extracts have different classes of substances with different effects on tumour cells and immune cells. Mistletoe extracts have glycoproteins (mistletoe lectins), polypeptides (viscotoxins), oligo- and polysaccharides, flavonoids, phenylpropane glycosides and triterpenes. These different constituents have different degrees of cytotoxicity and some of them produce induction of apoptosis and display antiangiogenesis. On immune cells, there is macrophage activation, release of Tumour Necrosis Factors and Interleukins, increase in phagocytosis, stimulation of T-helper cells, adjuvant increase in immune response, antioxidant and anti-inflammatory effects, immunoprotection. In general, the mistletoe constitutents show DNA stabilisation effects, which play an important role in prevention of recurrence.
The cytolytic and cytostatic effects are only seen on cancer cells, leaving healthy cells intact.
The whole extract is the active ingredient of the mistletoe and only the whole extract in its complexity is able to achieve the complex effects.

Mistletoe 4Each type of Helixor is available in about 9 different dose levels or strengths. Different packs have been created, for convenience of use depending on the different therapeutic needs of patients. The choice of the Helixor product allows the physician to ‘fine-tune’ the mistletoe therapy according to the individual situation of the patient.

Pharmacological effects of Helixor -

  • Immunomodulation creates reduced susceptibility to infections and indirect immune-mediated tumour inhibition.
  • DNA stabilization (immunoprotection) produces better tolerability of chemotherapy and less immunosuppression by chemotherapy.
  • Neuroendocrine effects lead to improved quality of life esp. reduction in fatigue.
  • Tumour inhibition effects (increased apoptosis and reduced angiogenesis) lead to prolongation of survival time and tumour regression in specific cases. These direct inhibition effects are only possible with the intratumoral application and are more moderate with a peritumoral application.

Therapeutic Indications -

  • Malignant tumours.
  • Relapse prevention following tumour surgery.
  • Defined precancerous conditions like chronic hepatitis B and C, ulcerative colitis, intestinal polyps, cervical intra-epithelial neoplasias.
  • Benign tumours like uterine fibroids, endometriosis, brain tumours.
  • Therapy is not contraindicated in patients undergoing surgery, chemotherapy or radiotherapy – however, close monitoring of the patient reaction and a reduction of dose may be needed.

Contraindications -

  • Allergies to mistletoe preparations
  • Florid autoimmune diseases, patients under immunosuppressive therapy
  • Hyperthyroidism with tachycardia
  • Acute inflammatory high febrile diseases (if temperature is over 38 C, it should not be administered that day)

Method of administration -

  • The injection has to be subcutaneous, ideally injected with a short needle at an angle of approx 45 degrees, after forming a 2-3 cm thick fold of skin. Insulin syringes are ideal for the purpose.
  • Preferred injection sites are the upper arms (not for breast cancer patients), abdomen and upper thighs.
  • The injection should be taken during morning hours, before noon.
  • The usual protocol is to inject Helixor 3 times a week on Mondays, Wednesdays and Fridays. From the 3rd year, depending on your response to the treatment, the physician may choose to give the injections twice a week. The physician will also choose a regular pattern for breaks of a fortnight after every 14 injections during the Maintenance Phase. The physician may choose to give daily injections in some cases.
  • Do not inject near inflamed skin areas, areas intended for surgery or near fresh surgical scars, avoid areas treated with radiotherapy.
  • Always inject at varying sites esp. during the Induction Phase.
  • The local reaction from the last injection must subside before the next injection is administered.

Duration of Helixor Therapy -

The treating physician decides on the duration of treatment, however certain guidelines exist.

  • So long as an increased risk of relapse exists, therapy for the prevention of relapse should be carried out.
  • Generally, a 2-year intensive therapy followed by subsequent phasing out with increasingly longer pauses/breaks can be recommended. In general, mistletoe therapy can be discontinued after 5 years.
  • In cases with tumours which tend towards late relapses (breast cancer, renal cell carcinoma, malignant melanoma), the prevention of relapse treatment should not be discontinued after the 5th year and should be continued as long-term treatment, using 2 series packs twice a year.
  • In cases of inoperable or metastasizing tumours and incurable systemic diseases, the palliative therapy should be continued indefinitely as long as the patient benefits.

Monitoring Helixor Therapy -

1) Local skin reaction – This is a local reaction on the skin at the site of the subcutaneous injection. This is an inflammatory response and is desirable – it is not a sign of intolerability or allergy – it shows that the skin’s immune cells have been activated by the administered dose. The ideal reaction is about 3 cm. If it approaches 5 cm or crosses that, you have to inform the physician guiding your Helixor therapy, so that the dose can be modified. This local reaction will likely be warm, slightly swollen and slightly itchy as well. It normally subdues within 2-3 days. It is best checked immediately prior to the next planned injection. Do not administer the next injection if the previous reaction still persists.
2) Temperature reaction – A temperature rise is a good sign of an increased release of transmitting agents of the immune system (cytokines).
A rise in temperature, between 0.5 – 1 C (0.9 – 1.8 F), is seen, usually 4-12 hours after the injection. This often leads to a feeling of warmth and not of cold/shivering. There should be a mild rise in mean temperature levels which is often very low in tumour patients. Also, there may be an increase in temperature amplitude by at least 0.5 C or 0.9 F, also on injection free days. This creates a good daily rhythm instead of the typically flat or chaotic temperature curve seen in tumour patients.
Ideally the patient should check oral/rectal temperature every 2 hours with an electronic thermometer, (with patient being at rest for about 30 minutes before measuring), for 2 days prior to starting the injections, so the physician can have a baseline graph. The thermometer tip should be placed deep below the tongue. During the Induction Phase, temperature mapping should ideally be done daily, about twice a day; once in the morning before getting up and again at the time of expected maximum temperature (which is determined by the temperature mapping done before the start of injections). During Maintenance Phase, temperature mapping can be done only for check-up purposes, for approx. 1 week every 3 months.
Your physician can provide you with a Temperature Control Chart in which entries can be made.
Based on these reactions, the ideal dose level for the patient is determined.
3) Blood tests (CBC) are also recommended from time to time – monthly in the induction phase, later every 3-6 months – we initially want an increase in WBCs with an increase in some immature forms. From week 3, we may see an increase in eosinophils. After 1-3 months an increase in absolute lymphocytes.
Advanced progressive tumours are accompanied by localized and systemic chronic inflammatory changes, which manifest as an increased ESR and increased C Reactive proteins. Successful mistletoe therapy leads to significant reduction of these inflammatory changes and this manifests as normalizing of ESR and CRP. These parameters are hence to be monitored for advanced metastasizing tumours.
[The temperature reaction and the immune tests (blood parameters) are not to be considered while the patient is taking chemotherapy. ]

Typical effects of Helixor -

  • Increasing performance and zest for life
  • Reduction of cancer-related fatigue
  • Normalization of body rhythms (temperature, sleep, digestion)
  • Increased appetite
  • Improvement of nausea/vomiting
  • Emotional well-being
  • Improvement of depression and anxiety
  • Decrease in tumour-related pain

Depending on the patient’s situation, the goal of therapy will differ and different treatment schedules are used. However, with any treatment schedule, dietary and lifestyle changes are also imperative. The Anthroposophic approach covers all aspects of life and treatments ideally should include conversation-free psychotherapy like art therapy and music therapy. When the human being focuses on his individual purpose in life and makes changes for the better, dramatic therapeutic results can often be seen.

Bibliography -

  1. Compendium of Mistletoe Therapy with Helixor in integrative Oncology – Helixor Heilmittel GmbH, Germany.
  2. Introduction to Anthroposophical Medicine – Robert Gorter, MD.
  3. Cancer as a Disease of Our Times – W. Bühler and R. Leroi. Translation by Dr. R. Goldberg, M.D., 1979.

Author: Michael Frass, Martin Bündner (ed.)  cover

Reviewed by: Dr. Firuzi Mehta

568 pages, hardbound.
First English edition 2015

Publishers: Narayana Verlag, Germany
ISBN: 978-3-95582-077-0

Price: Euros 59.00

On first hearing about this book that dealt with homeopathy, intensive care and emergency    medicine, I was impressed, intrigued and keen to read it. Most people have the impression that homeopathy is only for slow conditions;, that one needs time to get results, etc. Our literature does talk about quick results in life-threatening conditions, but those are few and far between. To have a whole book dedicated to the use of homeopathy in such situations is a marvellous thing indeed. So when I was offered a chance to review this book, of course, I jumped at it.

Let me first talk a bit about the authors of the book. Both the editors of this book, Michael Frass and Martin Bündner have long-standing experience in emergency medicine and homeopathy. Michael Frass was head of the intensive internal medicine unit at the Medical University of Vienna and Martin Bündner has served in rescue and emergency medicine.

A total of 19 physicians have contributed their cases for compiling this book; a vast majority of cases are by Michael Frass and Martin Bündner.

The book has four main sections:

I     Introduction

II   Intensive Care Medicine

III   Emergency Medicine

IV   Materia Medica

The Introduction starts with a chapter that covers a brief understanding of homeopathic principles and how homeopathy is used in a clinical setting. The second chapter discusses the development and current status of Intensive Medicine. The next chapter further discusses the use of homeopathic treatment alongside intensive medicine. Another chapter in the same section discusses remedy production and quality control. An ICU remedy kit has been compiled, which comprises 60 remedies. The table given discusses the English description of the homeopathic source material, the contents, the pharmacological effect, the allopathic indications and the frequent homeopathic indications of the remedy. For eg.,

2

The next section, on Intensive Care Medicine, has chapters on Infectious diseases, Disorders of Haemostasis, Heart, circulation and blood vessels, Lungs, Kidneys, Gastrointestinal tract, Perioperative care and Toxicology.

The third section on Emergency Medicine has chapters on Traumatology, Cardiovascular emergencies, Lungs, Gastroenterological emergencies, Intoxication, Neurological emergencies, Psychiatric emergencies, Gynaecology and obstetrics, Urological emergencies and Thermal emergencies.

The last section has a Materia Medica which gives a brief idea of the clinical indications, general information with main symptoms, ameliorating and aggravating circumstances which play an important role in the selection of the right homeopathic remedy.

The book has a total of 145 cases, all of them with a detailed analysis. To give an idea of the type of cases covered, here is a picture from the Table of contents.

3

Each topic starts with a quick overview of the definition of the clinical entity, incidence, mortality, symptoms, latest diagnostic methods, imaging techniques, blood cultures, therapy and the general outline of the homeopathic treatment, giving details of randomised, double-blind, placebo-controlled studies which have been made in an intensive care unit. Important rubrics from the repertory have been given and a differentiation between important homeopathic remedies given. This is followed by a critical commentary.

Cases then follow, starting with the anamnesis, the acute event, diagnosis, conventional treatment given and then the homeopathic treatment with rubric selection and progress of the case. Principles of classical homeopathy have been followed in most cases. This is again followed by an evaluation and a critical commentary.

The cases have been described in a clear and concise manner, highlighting the role of homeopathy in a situation where in many cases, conventional treatment was trying its best but the patient response was minimal. Most of the cases show remarkable and clear improvement in the patient’s condition after the homeopathic treatment was started. Some surgeries have been avoided and danger to life averted. Homeopathy has helped patients get weaned off life-support systems much earlier than otherwise possible.

The authors have discussed the difficulties of homeopathic treatment in an ICU set-up and the benefits of initial conventional life-saving and life-support methods. It is clear that the authors and editors have been balanced in their view point and there is no display of dangerous fanaticism.

This book shows how valuable our gentle but high-energy remedies can be in emergency situations in an ICU set-up. It would be wonderful if all ICUs would have the possibility of integrating homeopathy along with conventional medicine. After all, to benefit our patients; that isthe goal of any system of therapeutics, is to benefit the patients.

Reading this book will give hope and encouragement to young homeopaths that with hard work, acquiring knowledge of the Materia Medica and skill with the Repertory, even cases that look ‘difficult’ are manageable with our wonderful system of medicine, Homeopathy!

No review of mine is complete without a mention of the binding, paper quality, printing, etc. This book gets 9 on 10 in this department, simply because there are a couple of pages where some paragraphs have been wrongly repeated! Apart from that, wonderful smooth paper, good hardcover, excellent binding, good printing! No complaints. It was a pleasure to read this book. I think this book will encourage more homeopaths to venture into this arena of Intensive Care and Emergency Medicine.

This review was first published in June 2016 in the monthly Ezinehttp://hpathy.com/book-reviews/homeopathy-in-intensive-care-and-emergency-medicine-by-michael-frass-martin-bundner-ed-reviewed-by-dr-firuzi-mehta/

 —–

 This book review was first published at Hpathy.com in the November 2015 issue.

Author: Patricia Le RouxHomeokids

Reviewed by: Dr. Firuzi Mehta

224 pages, hardbound.

First English edition 2015

Publishers: Narayana Verlag, Germany

ISBN: 978-3-95582-008-4

Price: USD 44.00

 
Patricia Le Roux (1953 – 2011) was a French pediatric consultant and homeopath, trained in homeopathy at the Faculty of Medicine of Marseilles in France where she also taught the subject. She died after a tragic accident in October 2011 and the world has lost a very good practitioner.

I had read several of her articles in the magazine Spectrum and was always impressed with the clarity of her thought and understanding of the remedies and cases she presented. When the Hpathy editor Alan Schmukler offered me a chance to review this book, I immediately agreed.

Children form a considerable percentage of any homeopathic practice since even lay people understand that homeopathy is a safe system of medicine and free of the toxic side-effects of the chemical drugs used in conventional medicine. Children, with their systems relatively unspoiled, show positive results to the correct homeopathic remedy very rapidly. We have all seen children who come to our practice, with chronic ailments, some more severe than others, which cause not just suffering to the little child, but anxiety and stress to their families as well. Conventional medicine truly has nothing much to offer in chronic conditions. With strong chemical drugs, the chronic ailment is at best suppressed and some other chronic ailment manifests very quickly. Meanwhile, the child and his family run from one specialist to another. They often come to us, disheartened with conventional medicine, and with hope in their eyes that maybe, just maybe, this ‘other’ form of medicine can help their precious little one.

With our homeopathic knowledge, we have the ability to positively modify the long-term health prospects of these little children, going so far as to diminish disease tendencies that run in the family gene pool. This is a big responsibility and also a privilege. We need to make utmost use of all resources at hand, to do the best work we can.

This book, Homeo-Kids, by Patricia Le Roux is a good addition to our libraries. The book starts with a brief summary of the basic principles of homeopathy which are then followed by her description of the remedies. Of the sixty remedies she has described here, many are polychrests commonly seen in our practice but there are also some less well-known remedies for children like Beryllium, Helium, Falco peregrinus and Chocolate. To make our work easier, she has grouped them into four main types: chilly, hot, slow and restless.

In describing each remedy, she gives a few lines of introduction about what the remedy is useful for. This is followed by describing the source of the remedy. A box of key words (main features) follows. The detailed description of each remedy is divided into two main parts: The Baby and The Child and each of these is described with the following sub-headings:

At home
At the clinic
Main clinical indications

This is followed by a brief conclusion about the remedy.

Patricia Le Roux has covered all the main features, keynotes and distinguishing characteristics of each remedy. Development issues faced by different remedies are discussed along with the pathophysiology seen in them. Key phrases are highlighted in bold, allowing a quick review for differentiation in the clinic when necessary. Physical issues and the emotional, mental and psychological aspect of each remedy are dealt with, giving a clear understanding of each remedy type. With this book, not only has Patricia Le Roux demonstrated her clear knowledge of classical methods, but she has also demonstrated her understanding of the relatively new approaches of Jan Scholten and Rajan Sankaran. With her immense clinical experience, she has been able to offer valuable tips for recognising remedies even in very small children who may not display typical signs or symptoms. There is a Remedy Index and an Alphabetical Repertory for ailments towards the end of the book.

With this book, we should be better prepared to recognise the remedies when we see them in practice. The reaction of the organism to the right remedy is phenomenal and hopefully, putting this knowledge to good use, we should be able to get far better results, truly easing the suffering of our little patients and creating better all-round health for our future generations.

You will remain with us in spirit, dear Patricia. Thank you for this wonderful book.

This review by me was first published in the October 2014 e-zine issue of www.hpathy.com

———————————–

frei-oct14-image001Polarity Analysis in Homeopathy – A Precise Path to the Simillimum

Author: Heiner Frei

First English Edition 2013

Reviewed by Dr. Firuzi Mehta

Published by Narayana Publishers

ISBN: 978-3-95582-001-5

Hardbound

No. of pages:312

€ 49.00

 

In recent years, there has been renewed interest in Boenninghausen’s Therapeutic Pocket Book (TPB) that was first published in 1846. This repertory follows Boenninghausen’s premise that valuable modalities, sensations and findings of a remedy are capable of generalization. His TPB was valued greatly for its precise grading of symptoms but fell into disuse eventually probably due to the popularity of Kent’s philosophy and the apparent ease of use of Kent’s repertory. The value of the Therapeutic Pocket Book (TPB) was pretty much unknown to generations of homeopaths as homeopathic colleges focussed on Kent and his works while touching upon Boenninghausen’s works only cursorily.

Over the centuries, homeopathic fundamentals have remained the same but homeopaths have constantly striven to make remedy selection easier and more accurate. A lot of new methods and schools of thought have arisen from these endeavours. The ideal method needs to be one that can reliably and reproducibly determine the required remedy. Most of the new methods have not been statistically evaluated.

Polarity Analysis (PA) was developed by Heiner Frei for a scientifically rigorous Swiss double-blind study with homeopathic treatment of hyperactive children. This study demonstrated a significant difference between high-potency homeopathic remedies and placebo. The main challenge in reaching this result was to improve the reliability of all the factors used to determine the remedy.

Polarity Analysis is a development of Boenninghausen’s concept of contraindications. PA is a working method for the Therapeutic Pocket Book and Heiner Frei’s book provides us with a practical introduction to it.

The book consists of 3 Modules and an Appendix.

Module 1 describes Polarity Analysis in detail. It shows how PA follows the founding principles laid down by Hahnemann and the practical methods of old stalwarts like Boenninghausen, Hering and Lippe. It explains the value and use of Polar Symptoms (those symptoms that can have an opposite aspect, an opposite pole) in improving the reliability of the remedy choice. The author clearly explains the kind of case-taking that is required for suitable Polarity Analysis to take place. The author has simplified our work for us by creating valuable checklists and questionnaires for acute and chronic ailments. The symptoms used for these lists are from the Therapeutic Pocket Book and use the same language as the repertory. No symptom with less than 10 remedies in it is used. The patients themselves need to mark out their symptoms on the questionnaire which the homeopath can then confirm. Since these lists are built with repertory language and are specific to the TPB, this eliminates the possibility of errors creeping in due to faults in interpreting a patient’s symptoms and then converting them to repertory language.

frei-oct14-image002

These checklists and questionnaires are given towards the end of the book. They are also freely downloadable from the author’s website, www.heinerfrei.ch

frei-oct14-image003

Heiner Frei lays down, in simple language, the rules to be followed for PA to be most effective. He also clearly describes the dosage he follows and how follow-up assessments are judged.

The method of Polarity Analysis focuses on the Polarity Difference and also emphasises the importance given to contraindications. However, these details cannot be explained satisfactorily in a review.

 

Highlights of Polarity Analysis:

  • Mainly physical modalities are to be used, since they are the ones that are most reliable.
  • At least 5 polar symptoms should be used.
  • Characteristic symptoms during the ailment are to be used; not traits that are present even in health.
  • Mental symptoms are to be left for later, when remedy coverage is checked in the Materia Medica.

 

The repertorization results are weighted in the following order of importance:

  1. Absence of contraindications and size of polarity difference
  2. Completeness of symptom coverage
  3. Suitability of remedy in Materia Medica coverage.

frei-oct14-image004

Heiner Frei recommends the software program version V 2.6.0, 2012 of the Boenninghausen Arbeitsgemeinschaft (Boenninghausen Working Group). This software is preferred because it is the only one that uses the revised edition of the TPB that contains his final views on the grading of symptoms. A 30 day free trial version of this software is offered on www.boenninghausen.de

After describing the PA method in detail, Module 1 discusses the procedure to be followed in Acute Illness, along with case histories demonstrating the same.

Module 2 comprises procedure and case histories for Chronic Illness and for Mental Illness in Children and Teenagers.

Module 3 does the same for cases of Multimorbid Patients (those that have 3 or more complaints at the same time). Module 3 also has a section on Statistical Evaluation Studies of Polarity Analysis with and without checklists, comparing results with conventional homeopathic prescription methods. This is followed by a listing of the tools that are to be used for Polarity Analysis – the repertory, checklists, questionnaires and case logs.

Throughout the book, there are Quiz Questions which deal with the information covered till that point. These are very useful for clarifications and proper understanding of the topic. Answers to each Quiz are given in the Appendix at the end of the book.

My Impressions –

After a thorough reading which generated a lot of interest in this method, I downloaded the checklists and questionnaires from the author’s website www.heinerfrei.ch. I also downloaded the 30 day free trial version of the software offered at www.boenninghausen.de

I got some family members and friends to fill in the checklists and questionnaires and then worked out their cases with this method. I also used it for some of my patients where I was not too satisfied with the results so far. In some cases it confirmed the remedies already prescribed while in some it threw up some interesting possibilities that I had not considered earlier. After prescribing, some of the patients showed a good positive response. I am hopeful that this method will open up a new path to solving our cases successfully.

On the whole, the method is easy to understand and use. The case-taking method is also simple and saves time compared to conventional homeopathic history-taking. The checklists and questionnaires, being in TPB language, remove the possibility of errors in interpreting a patient’s symptoms. The software is perfectly adapted to Polarity Analysis and is very easy to use. The fact that the questionnaires have symptoms in language of the TPB also makes the use of the TPB very easy for someone who is not conversant with the book.

The Notes in red alongside the margins are very useful when a quick reference is needed.

frei-oct14-image005

For beginners who may be fumbling with all the different and complex methods out there in the homeopathic world, this is a welcome break, with an assurance of good results, especially with more practice. For busy practitioners, it saves time, yet delivers better results.

The paper and print quality of the book is excellent; we have come to expect these high standards from Narayana Publishers.

Thank you, Heiner Frei!!

This is not yet a true case study but for people following my posts on my website, I wanted to write about the great healing potential this remedy, Carcinosinum (58T) seems to have.

The basic Carcinosinum that we use is a remedy prepared from a single tumour – a breast tumour. This is the remedy of which Foubister made a detailed proving. Tinus Smits from Netherlands has used Carcinosinum (15T) with good results, better than those got from our regular single tumour Carcinosinum.

On a forum post at hpathy.com, there was a detailed discussion on the use of Carcinosinum (58T) http://forum.hpathy.com/forum/students-corner/carcinosinum/#p8599

Having my interest triggered, I ordered Carcinosinum (58T) in two potencies, 200c and 1M from Remedia Homoeopathic Pharmacy, in Austria.

I got the chance to use it after a few months of procuring it in a case of thrombocytosis and bone marrow fibrosis (that was secondary to the chemotherapeutic treatment for the thrombocytosis).

His allopathic treatment still continues but he has started concurrent homeopathy to prevent rapid degradation of his condition.

I have judged Carcinosin to be his remedy. I can say that there has been some amount of improvement in energy levels and the wild fluctuations in his counts are now a rare occurrence. However, his Haemoglobin that was remaining at around 8 or 8.5 gm% improved only marginally to settle at around 9.5 or 10 gm% despite his taking weekly erythropoetin injections as well. His ESR too has remained in the range of 80-100 since a long time now.

Since improvement seemed stuck at this level, I decided to give the Carcinosin (58T) a try. (I have already used Carcinosin 15T for him).

It is early days yet and only 3 weeks have passed since the dose of Carcinosin (58T) 200c was given. However, his recent reports show the Haemoglobin to have jumped from 10.3 gm% to 11 gm% and the ESR has come down to 49. Energy has been very good as well.  This makes me feel very positively towards this Carcinosin 58T and I hope, that there is a lot of improvement in the cards for this patient, even for his platelets and bone marrow fibrosis.

I hope to be able to continue to post about his improvement and about any more Carcinosinum (58T) cases that I may have.